These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31191748)

  • 1. Investigating the Protein Signature of Adamantinomatous Craniopharyngioma Pediatric Brain Tumor Tissue: Towards the Comprehension of Its Aggressive Behavior.
    Martelli C; Serra R; Inserra I; Rossetti DV; Iavarone F; Vincenzoni F; Castagnola M; Urbani A; Tamburrini G; Caldarelli M; Massimi L; Desiderio C
    Dis Markers; 2019; 2019():3609789. PubMed ID: 31191748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adamantinomatous craniopharyngioma: advances in proteomic research.
    Desiderio C; Rossetti DV; Castagnola M; Massimi L; Tamburrini G
    Childs Nerv Syst; 2021 Mar; 37(3):789-797. PubMed ID: 32617710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic characterization of pediatric craniopharyngioma intracystic fluid by LC-MS top-down/bottom-up integrated approaches.
    Martelli C; Iavarone F; Vincenzoni F; Rossetti DV; D'Angelo L; Tamburrini G; Caldarelli M; Di Rocco C; Messana I; Castagnola M; Desiderio C
    Electrophoresis; 2014 Aug; 35(15):2172-83. PubMed ID: 24729313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics in pediatric cystic craniopharyngioma.
    Massimi L; Martelli C; Caldarelli M; Castagnola M; Desiderio C
    Brain Pathol; 2017 May; 27(3):370-376. PubMed ID: 28414889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of thymosins β4 and β 10 in paediatric craniopharyngioma cystic fluid.
    Desiderio C; Martelli C; Rossetti DV; Di Rocco C; D'Angelo L; Caldarelli M; Tamburrini G; Iavarone F; Castagnola M; Messana I; Cabras T; Faa G
    Childs Nerv Syst; 2013 Jun; 29(6):951-60. PubMed ID: 23503632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do craniopharyngioma molecular signatures correlate with clinical characteristics?
    Omay SB; Chen YN; Almeida JP; Ruiz-Treviño AS; Boockvar JA; Stieg PE; Greenfield JP; Souweidane MM; Kacker A; Pisapia DJ; Anand VK; Schwartz TH
    J Neurosurg; 2018 May; 128(5):1473-1478. PubMed ID: 28707994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysis.
    Prince EW; Apps JR; Jeang J; Chee K; Medlin S; Jackson EM; Dudley R; Limbrick D; Naftel R; Johnston J; Feldstein N; Prolo LM; Ginn K; Niazi T; Smith A; Kilburn L; Chern J; Leonard J; Lam S; Hersh DS; Gonzalez-Meljem JM; Amani V; Donson AM; Mitra SS; Bandopadhayay P; Martinez-Barbera JP; Hankinson TC
    Neuro Oncol; 2024 Jun; 26(6):1109-1123. PubMed ID: 38334125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-depth proteomic profiling captures subtype-specific features of craniopharyngiomas.
    Kim JH; Kim H; Dan K; Kim SI; Park SH; Han D; Kim YH
    Sci Rep; 2021 Oct; 11(1):21206. PubMed ID: 34707096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma.
    Kato K; Nakatani Y; Kanno H; Inayama Y; Ijiri R; Nagahara N; Miyake T; Tanaka M; Ito Y; Aida N; Tachibana K; Sekido K; Tanaka Y
    J Pathol; 2004 Jul; 203(3):814-21. PubMed ID: 15221941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
    Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
    OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas.
    Burghaus S; Hölsken A; Buchfelder M; Fahlbusch R; Riederer BM; Hans V; Blümcke I; Buslei R
    Virchows Arch; 2010 Mar; 456(3):287-300. PubMed ID: 20069432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous Craniopharyngioma.
    Donson AM; Apps J; Griesinger AM; Amani V; Witt DA; Anderson RCE; Niazi TN; Grant G; Souweidane M; Johnston JM; Jackson EM; Kleinschmidt-DeMasters BK; Handler MH; Tan AC; Gore L; Virasami A; Gonzalez-Meljem JM; Jacques TS; Martinez-Barbera JP; Foreman NK; Hankinson TC;
    J Neuropathol Exp Neurol; 2017 Sep; 76(9):779-788. PubMed ID: 28859336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of inflammation in the genesis of the cystic component of craniopharyngiomas.
    Pettorini BL; Inzitari R; Massimi L; Tamburrini G; Caldarelli M; Fanali C; Cabras T; Messana I; Castagnola M; Di Rocco C
    Childs Nerv Syst; 2010 Dec; 26(12):1779-84. PubMed ID: 20668862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target.
    Apps JR; Carreno G; Gonzalez-Meljem JM; Haston S; Guiho R; Cooper JE; Manshaei S; Jani N; Hölsken A; Pettorini B; Beynon RJ; Simpson DM; Fraser HC; Hong Y; Hallang S; Stone TJ; Virasami A; Donson AM; Jones D; Aquilina K; Spoudeas H; Joshi AR; Grundy R; Storer LCD; Korbonits M; Hilton DA; Tossell K; Thavaraj S; Ungless MA; Gil J; Buslei R; Hankinson T; Hargrave D; Goding C; Andoniadou CL; Brogan P; Jacques TS; Williams HJ; Martinez-Barbera JP
    Acta Neuropathol; 2018 May; 135(5):757-777. PubMed ID: 29541918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated proteomic platforms for the comparative characterization of medulloblastoma and pilocytic astrocytoma pediatric brain tumors: a preliminary study.
    Martelli C; Iavarone F; D'Angelo L; Arba M; Vincenzoni F; Inserra I; Delfino D; Rossetti DV; Caretto M; Massimi L; Tamburrini G; Di Rocco C; Caldarelli M; Messana I; Castagnola M; Sanna MT; Desiderio C
    Mol Biosyst; 2015 Jun; 11(6):1668-83. PubMed ID: 25909245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric Brain Tumors: Signatures from the Intact Proteome.
    Rossetti DV; Inserra I; Nesticò A; Vincenzoni F; Iavarone F; Messana I; Castagnola M; Massimi L; Tamburrini G; Caldarelli M; Desiderio C
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin‑6 induces an epithelial‑mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration.
    Zhou J; Zhang C; Pan J; Chen L; Qi ST
    Mol Med Rep; 2017 Jun; 15(6):4123-4131. PubMed ID: 28487953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin.
    Stache C; Bils C; Fahlbusch R; Flitsch J; Buchfelder M; Stefanits H; Czech T; Gaipl U; Frey B; Buslei R; Hölsken A
    Neurosurg Focus; 2016 Dec; 41(6):E14. PubMed ID: 27903123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
    Wang Y; Deng J; Guo G; Tong A; Peng X; Chen H; Xu J; Liu Y; You C; Zhou L
    J Neurooncol; 2017 Jan; 131(1):21-29. PubMed ID: 27640198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the Canonical Wnt Pathway Activation on the Pathogenesis and Prognosis of Adamantinomatous Craniopharyngiomas.
    Jucá CEB; Colli LM; Martins CS; Campanini ML; Paixão B; Jucá RV; Saggioro FP; de Oliveira RS; Moreira AC; Machado HR; Neder L; Antonini SR; de Castro M
    Horm Metab Res; 2018 Jul; 50(7):575-581. PubMed ID: 29625497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.